OP.T
OPPOSITION TERMINATED NO. 999999
05/24/2023
Back to search
Official data from USPTO
AVACARE CLINICAL RESEARCH NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/08/2023
Trademark type
Combined
Nice classes
35, 42
Filing date
11/18/2019
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-02-00
First use in commerce
2020-02-00
Drawing code
3
Owner type
03
Owner location
Durham, NC
Examiner
PINO, BRIAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "AVACARE" in stylized letters, beginning with a capital letter "A" in which the horizontal element of the letter is formed from left to right by three circles of increasing size, a slightly larger oval, and a short line that becomes the top of the following lower case letter "V" in the following lowercase letter string "VACARE," which appears above the terms "CLINICAL RESEARCH NETWORK" centered thereunder in smaller uppercase font, all of which elements are in the color seafoam green.
Holders and representatives
Holders
QCare Site Services, Inc.
Representatives
ARLENE D HANKS MOORE & VAN ALLEN PLLC
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Site management organization servicesbusiness assistance services for other clinical research organizationsnew trial and study procurementbudgeting and contractingbusiness study feasibilitiescreation and implementation of standard operating proceduresproviding and managing study coordinators; development of comprehensive patient recruitment strategies; overseeing informed consent administration and managementbusiness administration and business management assistance for others; patient referral managementbusiness administration and business management assistance for others; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trialsapplications for drug approval and late phase and/or real world research studies; business data compilation and tracking services for othersinteractive tracking of clinical trial subject enrollmentstatus and adverse side effects of treatment and medicationincluding interactive services on mobile platform; business consulting servicesconsulting regarding regulatory inspections and biopharmaceutical and biotechnology audits
Class 42
Medical and scientific researchconducting clinical trials and translational research for others; clinical research services during clinical trials of pharmaceuticals and medical devicesdata collection service using software to evaluateanalyzecollect clinical data; multitherapeutic site management organization servicesresearch and development services in the field of pharmaceuticals and drug development
Publications
History of USPTO decisions and trademark events.
26 publications found
OP.D
OPPOSITION DISMISSED NO. 999999
05/24/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/12/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/11/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/25/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/24/2023
IUAF
USE AMENDMENT FILED
03/10/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/13/2022
OP.I
OPPOSITION INSTITUTED NO. 999999
06/05/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2020
PUBO
PUBLISHED FOR OPPOSITION
04/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2020
ALIE
ASSIGNED TO LIE
03/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
02/27/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/27/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/27/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/27/2020
DOCK
ASSIGNED TO EXAMINER
02/21/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/23/2019
NWAP
NEW APPLICATION ENTERED
11/21/2019
Continuous trademark protection
Get notified about every new filing that threatens AVACARE CLINICAL RESEARCH NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.